AXGN
Axogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$35.24
+1.79%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$34.86
From 52W high−31.88%
Volume735472.00
Market cap$2.07B
P/E (TTM)—
P/S (TTM)8.2x
Div yield—
Key dataOct 19, 2026
Open
$34.86
From 52W high
−31.88%
Volume
735472.00
Market cap
$2.07B
ValuationView details →
P/E (Fwd)
54.1x
EV/EBITDA
−159.3x
P/E (TTM)
—
RSI (14)
27.0
MomentumView details →
1D Return
+1.79%
YTD Return
+5.41%
SummaryUpdated Jun 1, 2026
AxoGen, Inc. (NASDAQ:AXGN) is a medical device company founded in 1986 and headquartered in Alachua, Florida. The company specializes in developing and marketing surgical solutions for peripheral nerve repair and reconstruction. AxoGen has evolved from its early days to become a leading provider of biologically-based nerve repair products, serving surgeons across multiple specialties including plastic reconstruction, orthopedic hand surgery, and oral and maxillofacial surgery. The company operates primarily in the United States but has expanded internationally to Canada, Germany, the United Kingdom, South Korea, and other markets.
Similar companies
Latest newsMore news →
Axogen, Inc. announced that it will report its third-quarter 2026 financial results on October 28, 2026.6d agoAxogen, Inc. announced the pricing of an underwritten public offering of 4,910,000 shares of its common stock at $42.50 per share, expecting gross proceeds of approximately $208.7 million.40d ago